4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-23-053251
President and CFO sold 8,000 shares at an average $45.91 ($367,300)
- President and CFO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GUGGENHIME ANDREW · President and CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $5.35 | $42,800 | 87,474 | D |
| 2023-10-18 | Sale : show line 2 in the form 10b5-1 | −7,497 | $45.89 | $344,000 | 79,977 | D |
| 2023-10-18 | Sale : show line 3 in the form 10b5-1 | −503 | $46.32 | $23,300 | 79,474 | D |
| Open-market sales · 8,000 sh · avg $45.91 · $367,300 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-18 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −8,000 | 422,827 | D |
Loading xslF345X05/doc4.xml…